Eme Coerver

6PUBLICATIONS
15CO-AUTHORS
Neurology and neuromuscular diseasesMedical infection agents (incl. prions)Predictive and prognostic markersApplications in health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 04, 2026
Brain atrophy rates vary with age in relapsing-remitting multiple sclerosis.

Sezgi Kaçar, David R van Nederpelt, Julia R Jelgerhuis

|Sep 09, 2024
Aging is associated with reduced inflammatory disease activity independent of disease duration in relapsing multiple sclerosis trial populations.

Eline Me Coerver, Sezgi Kaçar, Olga Ciccarelli

|May 12, 2023
Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosis.

Eva M Strijbis, Eline Coerver, Jop Mostert

|Jun 14, 2021
Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients.

Zygj van Lierop, A A Toorop, Eme Coerver

|Nov 05, 2020
Real-world keystroke dynamics are a potentially valid biomarker for clinical disability in multiple sclerosis.

K H Lam, K A Meijer, F C Loonstra

Pageof 1